Precision Biosciences Inc
Biotechnology company · Durham, North Carolina, United States · Nasdaq: DTIL
Precision Biosciences Inc is a biotechnology company headquartered in Durham, North Carolina, United States. Its shares trade on Nasdaq under the ticker DTIL. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $502,296 in total, most recently in 2010. It has reported private securities offerings to the US SEC, most recently $40 million sold in a notice filed in 2019.
Precision Biosciences at a glance
What does Precision Biosciences do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $502,296 in total (2008 to 2010).
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $39.5 million sold (2019).
Frequently asked questions about Precision Biosciences
Where is Precision Biosciences headquartered?
Precision Biosciences Inc is headquartered in Durham, North Carolina, United States.
What does Precision Biosciences do?
Precision Biosciences Inc is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Precision Biosciences a public company?
Yes. Precision Biosciences Inc trades on Nasdaq under the ticker DTIL.
Similar companies
- Humacyte, Inc.Durham, North Carolina, United States
- Xilis, Inc.Durham, North Carolina, United States
- Deep Blue Medical Advances, Inc.Durham, North Carolina, United States
- inSoma Bio, Inc.Durham, North Carolina, United States
- Atsena Therapeutics, Inc.Durham, North Carolina, United States
- Scion Neurostim, Inc.Durham, North Carolina, United States
- Sapere Bio, Inc.Durham, North Carolina, United States
- BioAesthetics CorpDurham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.